Best ozempic face treatments in Toronto

Ozempic face treatments in Toronto

Treating Ozempic facial volume loss after GLP-1 weight loss

Losing weight on a GLP-1 medication changes the face faster than it changes the body. Clients tell us their body looks the way they hoped and their face looks tired, hollow, and older than it did a year ago. That gap is what people mean when they say “Ozempic face”.

We treat this differently than most clinics in Toronto. Rather than filling the hollows first, we start by rebuilding the skin’s own structure, then add volume once the foundation can hold it. Timing matters more than most people realise, and the window is narrower than you would expect.

What Ozempic face actually is

Ozempic face is facial volume loss and skin laxity that follows rapid weight loss on a GLP-1 medication. It is not a side effect of the drug itself. It is what happens when fat disappears from the face quickly and the skin does not contract at the same pace.

The same pattern appears with every medication in this class, which is why you will also hear it called Wegovy face or Mounjaro face. The medications we see most often in our King West clinic are Ozempic and Wegovy (semaglutide), Mounjaro and Zepbound (tirzepatide), and Saxenda (liraglutide). The facial changes are the same regardless of which one you are taking.

What clients notice first:

  • Hollowing through the cheeks and temples
  • A gaunt or drawn look, particularly in photographs
  • Deeper nasolabial folds and marionette lines
  • Loss of definition along the jawline
  • Skin that looks thinner or crepey
  • Being told they look tired when they feel well

Why the face loses volume before the body does

The fat that disappears first is superficial fat, the layer sitting just beneath the skin across the cheeks, temples and midface. It is metabolically active and it is what gives a face its softness and light reflection.

Deeper structural fat is more stable. So the face does not simply get smaller, it loses its top layer of cushioning while the underlying framework stays put. That is why the result reads as gaunt rather than slim, and why the skin above it has nothing left to rest on.

This is also why the treatment approach matters. Restoring volume deep under the skin does not correct a problem that occurred superficially. The correction has to happen at the layer where the loss actually occurred.

Our approach: Collagen first, filler second

This is where we differ from most clinics treating this concern.

We start with collagen-stimulating injectables, Sculptra and Radiesse, rather than with hyaluronic acid filler. Both work at the superficial level, the same layer where the fat was lost, and both prompt your own tissue to rebuild rather than simply occupying space.

Once that structure is in place, the skin is firmer and better able to support filler. Dermal fillers then do a smaller, more precise job, replacing what remains after the weight has stabilized. Less product, better integration, and a result that reads as a face rather than as work.

Filling a slack, unsupported face first is how people end up looking puffy or overfilled. The volume sits where it was placed instead of settling into supported tissue. Sequencing the treatments in the right order is most of what separates a natural result from an obvious one.

The first three months matter

In our clinical experience, patients respond considerably better to Sculptra and Radiesse when they are treated within roughly the first three months of starting a GLP-1 medication.

After that point, the collagen response to these injectables appears to diminish. We believe this relates to the hormonal shifts these medications produce and to reduced nutritional intake as appetite drops. The raw materials for building collagen become less available at precisely the moment the skin needs them most.

There is also emerging evidence that Sculptra can stimulate regeneration of fat cells in the superficial layers of the skin. Those fat cells carry the stem cells that drive that regeneration, which suggests treating before they are depleted produces a better outcome.

The practical takeaway: if you have started a GLP-1 and are concerned about your face, the best time to come in is now, not after the weight is gone. Prevention is a far easier project than correction.

Treatments we use for Ozempic face

Sculptra

Poly-L-lactic acid, injected superficially to stimulate your own collagen. Results build gradually over three to six months and hold for up to two years or more. This is our primary treatment for facial volume loss across the cheeks, temples and midface.

Learn more about Sculptra →

Radiesse

Calcium hydroxylapatite, which provides immediate structure and stimulates collagen over the following months. We use it where the face needs both lift and rebuilding, and in hyperdilute form where the concern extends into the neck and jawline.

Learn more about Radiesse →

Dermal Fillers

Hyaluronic acid fillers for targeted volume replacement, used once collagen stimulation has done its work and your weight has settled. Placed conservatively and in specific areas rather than across the whole face.

Learn more about dermal fillers →

Sofwave

FDA-approved and Health Canada-approved ultrasound treatment for skin laxity, delivered at 1.5mm into the mid-dermis. One session, no downtime. Useful when the jawline and lower face have lost definition alongside the volume loss.

Learn more about Sofwave →

Sylfirm X

Radiofrequency microneedling for skin quality, texture and firmness. We were the first clinic in Ontario to offer it. This addresses the crepey, thinned quality that often accompanies rapid weight loss.

Learn more about Sylfirm X →

What your treatment plan might look like

Every plan starts with a complimentary consultation, where we assess where the volume has actually been lost and how your skin is behaving.

A typical sequence for someone early in their GLP-1 journey:

  1. Months 0-3: Sculptra or Radiesse to stimulate collagen while the response is strongest. Usually two to three sessions spaced several weeks apart.
  2. Months 3-6: Sofwave or Sylfirm X if skin laxity or texture is a concern alongside volume loss.
  3. Once weight is stable: A conservative amount of dermal filler to address any remaining hollowing, now supported by firmer tissue.


Someone further along in their weight loss follows a similar sequence, though we set expectations differently about how much collagen response to anticipate.

Start with a consultation

Our team is made up of Registered Nurses and Nurse Practitioners, and we have been treating clients in King West for over five years. We work conservatively, we explain the reasoning behind every recommendation, and we will tell you plainly if we think a treatment will not serve you.

If you are on a GLP-1 medication and concerned about what is happening to your face, come in and talk to us. The earlier in your weight loss journey we see you, the more we can do.

Ozempic face frequently asked questions

No. This is the most common misconception we encounter. Waiting means missing the window when your skin responds best to collagen stimulation. We treat with Sculptra or Radiesse early, then use filler once your weight has settled.

Not when it is sequenced properly and placed conservatively. Puffiness usually results from filling a face that has no structural support, so the product sits on top rather than integrating. Building collagen first means you need less filler and it settles more naturally.

Largely, yes. Starting collagen stimulation within the first three months of your GLP-1 is the most effective preventive step we know of. Supporting it with adequate protein intake and medical-grade skincare helps as well.

The volume loss will not reverse on its own, though it is treatable. Some skin retraction occurs naturally over the first year, but the fat that has gone does not return without intervention.

Cost depends on which treatments your plan involves and how many sessions are needed. We give you a full breakdown at your complimentary consultation, with no obligation to book anything.

No. Any rapid weight loss produces the same effect, and it occurs across all GLP-1 medications including Wegovy, Mounjaro, Zepbound and Saxenda. Ozempic simply became the name attached to it.